dicyclomine hydrochloride capsule
redpharm drug, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)], nursing mothers [see use in specific populations (8.3)], and in patients with: unstable cardiovascular status in acute hemorrhage myasthenia gravis [see warnings and precautions (5.4)] glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] obstructive uropathy [see warnings and precautions (5.8)] obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] severe ulcerative colitis [see warnings and precautions (5.7)] reflux esophagitis 8.1 pregnancy pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malforma
dicyclomine hydrochloride capsule
nucare pharmaceuticals, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations ( 8.4)] , nursing mothers [see use in specific populations ( 8.3)] , and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions ( 5.4)] - glaucoma [see adverse reactions ( 6.3) and drug interactions ( 7.1)] - obstructive uropathy [see warnings and precautions ( 5.8)] - obstructive disease of the gastrointestinal tract [see warnings and precautions ( 5.5)]
dicyclomine hydrochloride capsule
h.j. harkins company inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)], nursing mothers [see use in specific populations (8.3)] and in patients with: • unstable cardiovascular status in acute hemorrhage • myasthenia gravis [see warnings and precautions (5.4)] • glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] • obstructive uropathy [see warnings and precautions (5.8)] • obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] • severe ulcerative colitis [see warnings and precautions (5.7)] • reflux esophagitis 8.1 pregnancy teratogenic effects. pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine in pregnant women at the recommended doses of 80 mg/day to 160 mg/day. however, epidemio
dicyclomine hydrochloride tablet
redpharm drug, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)], nursing mothers [see use in specific populations (8.3)] and in patients with: • unstable cardiovascular status in acute hemorrhage • myasthenia gravis [see warnings and precautions (5.4)] • glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] • obstructive uropathy [see warnings and precautions (5.8)] • obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] • severe ulcerative colitis [see warnings and precautions (5.7)] • reflux esophagitis 8.1 pregnancy teratogenic effects. pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine in pregnant women at the recommended doses of 80 mg/day to 160 mg/day. however, epidemiologic
dicyclomine hydrochloride tablet
preferred pharmaceuticals inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] and in patients with: adequate and well-controlled studies have not been conducted with dicyclomine in pregnant women at the recommended doses of 80 mg/day to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to women who took products containing dicyclomine hydrochloride at doses up to 40 mg/day during the first trimester of pregnancy. reproduction studies have been performed in rats and rabbits at doses up to 33 times the maximum recommended human dose based on 160 mg/day (3 mg/kg) and have revealed no evidence of harm to the fetus due to dicyclomine. because animal reproduction studies are not always predictive of human response, this drug shoul
dicyclomine hydrochloride tablet
aphena pharma solutions - tennessee, llc - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] and in patients with: adequate and well-controlled studies have not been conducted with dicyclomine in pregnant women at the recommended doses of 80 mg/day to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to women who took products containing dicyclomine hydrochloride at doses up to 40 mg/day during the first trimester of pregnancy. reproduction studies have been performed in rats and rabbits at doses up to 33 times the maximum recommended human dose based on 160 mg/day (3 mg/kg) and have revealed no evidence of harm to the fetus due to dicyclomine. because animal reproduction studies are not always predictive of human response, this drug shoul
dicyclomine hydrochloride tablet
redpharm drug, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)], nursing mothers [see use in specific populations (8.3)], and in patients with: unstable cardiovascular status in acute hemorrhage myasthenia gravis [see warnings and precautions (5.4)] glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] obstructive uropathy [see warnings and precautions (5.8)] obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] severe ulcerative colitis [see warnings and precautions (5.7)] reflux esophagitis 8.1 pregnancy teratogenic effects: pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased r
dicyclomine hydrochloride tablet
remedyrepack inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations ( 8.4)] , nursing mothers [see use in specific populations ( 8.3)] , and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions ( 5.4)] - glaucoma [see adverse reactions ( 6.3) and drug interactions ( 7.1)] - obstructive uropathy [see warnings and precautions ( 5.8)] - obstructive disease of the gastrointestinal tract [see warnings and precautions ( 5.5)]
dicyclomine hydrochloride capsule
proficient rx lp - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] and in patients with: adequate and well-controlled studies have not been conducted with dicyclomine in pregnant women at the recommended doses of 80 mg/day to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to women who took products containing dicyclomine hydrochloride at doses up to 40 mg/day during the first trimester of pregnancy. reproduction studies have been performed in rats and rabbits at doses up to 33 times the maximum recommended human dose based on 160 mg/day (3 mg/kg) and have revealed no evidence of harm to the fetus due to dicyclomine. because animal reproduction studies are not always predictive of human response, this drug shoul
dicyclomine hydrochloride capsule
remedyrepack inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride capsules, usp are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific p opu l a ti on s (8.4) ] , nursing mothers [see use in specific populations (8.3)] and in patients with: • unstable cardiovascular status in acute hemorrhage • myasthenia gravis [see warnings and precautions (5.4)] • glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] • obstructive uropathy [see warnings and precautions (5.8)] • obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] • severe ulcerative colitis [see warnings and precautions (5.7)] • reflux